Copel (NYSE: ELPC)

$11.01+2.23%today

Brazilian ADR trading on the NYSE, priced in US dollars.

Display currency

Market Cap, EPS and the financial totals below — switch between US dollars and BRL.

Market Cap: $8.17B
P/E (TTM): 13.4x
P/B: 7.4x
EPS (TTM): $0.82
Dividend Yield: 4.92%
52-Week Range: $8.08 – $13.70
Volume: 464K
Previous Close: $10.77

TTM = trailing twelve months — the most recent 12 months (a rolling window), used for P/E, EPS and dividends. On the tables and charts below, the in-progress current year appears as a “Last 12M” column labelled with the quarter range it covers.

Performance

Today

+2.23%

1 Week

+3.87%

1 Month

-3.67%

YTD

+15.77%

1 Year

+32.97%

5 Years

—

About Copel

US Ticker: ELPC
B3 Ticker: CPLE3
Exchange: NYSE
Currency: USD
Sector: Utilities
Industry: Utilities - Regulated Electric
Headquarters: Curitiba, PR, Brazil
Employees: 4,287
CEO: Mr. Daniel Pimentel Slaviero
Founded: 1954

Companhia Paranaense de Energia - COPEL, together with its subsidiaries, engages in the research, study, planning, construction, production, transformation, transportation, distribution, and commercialization of electricity in Brazil.

The company operates through three segments: Generation and Transmission of Electrical Energy; Electrical Energy Distribution; and Commercialization.

It produces electricity from hydroelectric and wind power; and constructs, operates, and maintains substations, as well as lines for energy transmission.

The company was formerly known as Companhia Paranaense de Energia Elétrica and changed its name to Companhia Paranaense de Energia - COPEL in October 1979.

Companhia Paranaense de Energia - COPEL was founded in 1954 and is headquartered in Curitiba, Brazil.

www.copel.com

Analyst Ratings

Consensus of 3 Wall Street analysts · sourced from Yahoo Finance

1.0Strong Buy

On a 1–5 scale: 1 = Strong Buy, 3 = Hold, 5 = Sell. Lower is more bullish.

12-Month Price Target

Low

$14.80

Average

$17.27

High

$22.00

The average target is +56.83% above the current price of $11.01.

Financial Results

Revenue, EBITDA and net profit (in USD) with net margin (net profit ÷ revenue).

Financial Health

Margins, leverage and cash-flow quality derived from Copel's income statement, balance sheet and cash flow (absolute figures in USD).

ProfitabilityLeverageGrowth

Overall: Financially Strong

Net Margin: 11.4%
ROE: 13.2%
Rev Growth (YoY): +23.45%
Net Debt / EBITDA: 2.86×
Current Ratio: 1.30×
Interest Coverage: 3.59×
Free Cash Flow: 1.09B
Payout Ratio: 78.9%

Income — Margins & Efficiency

Metric	Last 12MQ3'25 – Q2'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011	Δ	2010	Δ	2009	Δ	2008	Δ	2007	Δ	2006
Revenue	$5,403,677,965	+26.9%	$4,258,113,732	+2.4%	$4,157,297,605	-2.6%	$4,267,896,201	+12.2%	$3,805,518,884	+255.4%	-$2,448,805,153	-173.7%	$3,322,382,319	-13.0%	$3,819,496,727	+6.4%	$3,590,313,618	-18.6%	$4,408,995,253	+9.7%	$4,019,805,787	+6.1%	$3,787,881,491	-34.1%	$5,745,517,468	+38.8%	$4,140,827,244	-1.4%	$4,199,175,319	-1.3%	$4,254,617,826	+4.6%	$4,068,812,570	+15.9%	$3,512,103,844	+24.0%	$2,832,638,680	-1.1%	$2,865,452,093	+32.4%	$2,164,101,438
Gross profit	$1,463,879,903	+59.2%	$919,493,185	+660.7%	$120,868,920	-87.6%	$973,223,653	+6.5%	$913,560,839	+116.6%	-$5,519,152,287	-685.6%	$942,412,631	-11.1%	$1,060,242,852	+35.2%	$784,059,022	-25.7%	$1,055,890,786	+20.0%	$879,832,479	+10.3%	$797,457,485	-28.2%	$1,111,188,472	+21.2%	$916,506,991	-5.1%	$965,398,991	-23.9%	$1,268,889,862	+11.8%	$1,134,938,978	+24.6%	$911,078,894	-11.6%	$1,030,219,501	-18.0%	$1,256,604,075	+43.4%	$876,067,779
Operating income	$1,059,886,176	+56.4%	$677,492,621	+461.7%	$120,612,308	-80.9%	$632,972,103	+166.8%	$237,256,403	-55.7%	$535,555,984	-38.6%	$872,278,368	+34.1%	$650,379,080	+34.8%	$482,640,462	+10.2%	$437,907,825	-19.9%	$546,681,803	+8.3%	$504,670,654	-23.9%	$663,273,944	+19.9%	$553,086,604	+15.4%	$479,410,660	-30.5%	$690,245,117	+30.0%	$530,902,659	-16.3%	$634,160,486	-27.8%	$878,540,294	-18.3%	$1,074,902,533	+50.1%	$716,037,265
EBITDA	$1,372,446,737	+64.1%	$836,378,043	+2.4%	$816,575,755	+3.7%	$787,163,011	+87.3%	$420,174,753	-59.5%	$1,036,372,273	-5.4%	$1,095,142,821	+18.8%	$921,997,208	+44.5%	$638,144,200	-8.2%	$694,802,100	+5.4%	$659,489,461	+8.2%	$609,353,473	-41.4%	$1,039,764,769	+8.5%	$958,471,358	+26.1%	$759,976,268	-35.5%	$1,177,744,159	+2.8%	$1,145,144,154	+5.3%	$1,087,120,139	-11.0%	$1,221,503,295	-7.7%	$1,323,648,678	+9.0%	$1,214,353,414
Net profit	$617,182,293	+16.9%	$528,175,768	+533.5%	$83,379,774	-81.4%	$448,817,756	+117.8%	$206,072,236	-77.4%	$910,115,038	+30.7%	$696,134,726	+45.3%	$478,951,093	+38.0%	$347,191,502	+6.8%	$324,947,656	+18.2%	$274,835,701	-2.3%	$281,204,602	-43.2%	$495,073,689	+2.3%	$483,788,904	+39.7%	$346,429,348	-45.3%	$633,413,580	+8.8%	$582,399,033	+30.9%	$444,917,959	-20.5%	$559,775,829	-8.1%	$609,366,740	+6.1%	$574,543,437
Gross margin	27.1%	+5.5 p.p.	21.6%	+18.7 p.p.	2.9%	-19.9 p.p.	22.8%	-1.2 p.p.	24.0%	-201.4 p.p.	225.4%	+197.0 p.p.	28.4%	+0.6 p.p.	27.8%	+5.9 p.p.	21.8%	-2.1 p.p.	23.9%	+2.1 p.p.	21.9%	+0.8 p.p.	21.1%	+1.7 p.p.	19.3%	-2.8 p.p.	22.1%	-0.9 p.p.	23.0%	-6.8 p.p.	29.8%	+1.9 p.p.	27.9%	+2.0 p.p.	25.9%	-10.4 p.p.	36.4%	-7.5 p.p.	43.9%	+3.4 p.p.	40.5%
Operating margin	19.6%	+3.7 p.p.	15.9%	+13.0 p.p.	2.9%	-11.9 p.p.	14.8%	+8.6 p.p.	6.2%	+28.1 p.p.	-21.9%	-48.1 p.p.	26.3%	+9.2 p.p.	17.0%	+3.6 p.p.	13.4%	+3.5 p.p.	9.9%	-3.7 p.p.	13.6%	+0.3 p.p.	13.3%	+1.8 p.p.	11.5%	-1.8 p.p.	13.4%	+1.9 p.p.	11.4%	-4.8 p.p.	16.2%	+3.2 p.p.	13.0%	-5.0 p.p.	18.1%	-13.0 p.p.	31.0%	-6.5 p.p.	37.5%	+4.4 p.p.	33.1%
EBITDA margin	25.4%	+5.8 p.p.	19.6%	+0.0 p.p.	19.6%	+1.2 p.p.	18.4%	+7.4 p.p.	11.0%	+53.4 p.p.	-42.3%	-75.3 p.p.	33.0%	+8.8 p.p.	24.1%	+6.4 p.p.	17.8%	+2.0 p.p.	15.8%	-0.6 p.p.	16.4%	+0.3 p.p.	16.1%	-2.0 p.p.	18.1%	-5.0 p.p.	23.1%	+5.0 p.p.	18.1%	-9.6 p.p.	27.7%	-0.5 p.p.	28.1%	-2.8 p.p.	31.0%	-12.2 p.p.	43.1%	-3.1 p.p.	46.2%	-9.9 p.p.	56.1%
Net margin	11.4%	-1.0 p.p.	12.4%	+10.4 p.p.	2.0%	-8.5 p.p.	10.5%	+5.1 p.p.	5.4%	+42.6 p.p.	-37.2%	-58.1 p.p.	21.0%	+8.4 p.p.	12.5%	+2.9 p.p.	9.7%	+2.3 p.p.	7.4%	+0.5 p.p.	6.8%	-0.6 p.p.	7.4%	-1.2 p.p.	8.6%	-3.1 p.p.	11.7%	+3.4 p.p.	8.2%	-6.6 p.p.	14.9%	+0.6 p.p.	14.3%	+1.6 p.p.	12.7%	-7.1 p.p.	19.8%	-1.5 p.p.	21.3%	-5.3 p.p.	26.5%
Revenue growth (YoY)	23.4%	+23.4 p.p.	0.0%	-5.5 p.p.	5.5%	+0.9 p.p.	4.6%	+258.7 p.p.	-254.1%	-82.6 p.p.	-171.5%	-188.9 p.p.	17.4%	+8.4 p.p.	9.1%	+5.3 p.p.	3.7%	-3.3 p.p.	7.0%	+19.4 p.p.	-12.3%	-19.1 p.p.	6.8%	-45.7 p.p.	52.5%	+44.4 p.p.	8.1%	-1.1 p.p.	9.2%	-3.5 p.p.	12.7%	+2.3 p.p.	10.4%	-4.1 p.p.	14.5%	+9.6 p.p.	4.9%	-6.3 p.p.	11.2%	—	—
Effective tax rate	14.7%	-6.0 p.p.	20.6%	+0.0 p.p.	20.6%	+6.4 p.p.	14.2%	+44.0 p.p.	-29.8%	-55.5 p.p.	25.7%	+0.6 p.p.	25.1%	+1.4 p.p.	23.7%	-1.9 p.p.	25.6%	+5.9 p.p.	19.7%	-17.6 p.p.	37.3%	+5.9 p.p.	31.4%	+3.3 p.p.	28.1%	+1.2 p.p.	26.9%	+1.6 p.p.	25.3%	-0.4 p.p.	25.7%	-1.1 p.p.	26.8%	+3.2 p.p.	23.7%	-5.8 p.p.	29.5%	+0.7 p.p.	28.8%	-1.9 p.p.	30.7%
Interest coverage	3.59×	-90.8%	39.05×	+0.0%	39.05×	+1022.0%	3.48×	-69.3%	11.32×	-89.7%	110.29×	+182.2%	39.09×	+233.4%	11.72×	-68.2%	36.87×	+113.4%	17.28×	-43.6%	30.65×	-39.6%	50.73×	+356.3%	11.12×	-88.9%	99.95×	+49.3%	66.96×	-29.0%	94.35×	+30.0%	72.60×	+1620.9%	4.22×	-14.7%	4.94×	-5.9%	5.25×	+1.5%	5.18×

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Balance Sheet — Health & Leverage

Metric	Last 12MQ3'25 – Q2'26	Δ	2025	Δ	2024	Δ	2023	Δ	2022	Δ	2021	Δ	2020	Δ	2019	Δ	2018	Δ	2017	Δ	2016	Δ	2015	Δ	2014	Δ	2013	Δ	2012	Δ	2011	Δ	2010	Δ	2009	Δ	2008	Δ	2007	Δ	2006
Net debt	$3,922,365,355	+55.6%	$2,521,426,074	+2.4%	$2,461,728,182	+29.1%	$1,907,117,708	+2.4%	$1,862,332,197	+18.3%	$1,574,131,246	+28.7%	$1,223,451,430	-41.8%	$2,100,454,896	-12.6%	$2,402,114,886	-13.1%	$2,763,497,123	+14.7%	$2,410,035,590	+51.4%	$1,591,672,200	-27.0%	$2,181,644,156	+73.4%	$1,258,501,128	+41.2%	$891,099,575	+44.7%	$615,717,569	+447.3%	$112,503,980	+29.3%	$87,040,908	+228.5%	$26,494,214	-91.4%	$309,241,189	-42.2%	$535,410,329
Net Debt / Equity	0.84×	+61.0%	0.52×	-0.1%	0.52×	+30.2%	0.40×	-16.8%	0.48×	+23.1%	0.39×	+14.1%	0.34×	-32.0%	0.51×	-16.7%	0.61×	+5.0%	0.58×	+8.3%	0.53×	+20.4%	0.44×	+11.2%	0.40×	+80.8%	0.22×	+48.0%	0.15×	+56.6%	0.10×	+450.0%	0.02×	+15.0%	0.02×	+137.3%	0.01×	-91.8%	0.08×	-57.3%	0.18×
Net Debt / EBITDA	2.86×	-5.2%	3.01×	+0.0%	3.01×	+24.4%	2.42×	-45.3%	4.43×	+191.8%	1.52×	+36.0%	1.12×	-51.0%	2.28×	-39.5%	3.76×	-5.4%	3.98×	+8.8%	3.65×	+39.9%	2.61×	+24.5%	2.10×	+59.8%	1.31×	+12.0%	1.17×	+124.3%	0.52×	+432.1%	0.10×	+22.7%	0.08×	+269.1%	0.02×	-90.7%	0.23×	-47.0%	0.44×
Debt / Equity	0.98×	+42.7%	0.68×	-0.1%	0.69×	+7.5%	0.64×	+4.3%	0.61×	+10.9%	0.55×	+9.1%	0.51×	-25.3%	0.68×	-7.2%	0.73×	+12.7%	0.65×	+7.7%	0.60×	+9.6%	0.55×	+20.7%	0.45×	+26.8%	0.36×	+32.9%	0.27×	+46.6%	0.18×	+2.2%	0.18×	+10.7%	0.16×	-29.8%	0.23×	-20.3%	0.29×	-30.4%	0.42×
Current ratio	1.30×	+3.2%	1.26×	+0.0%	1.26×	-14.4%	1.47×	+13.0%	1.30×	-7.1%	1.40×	+18.7%	1.18×	-20.1%	1.48×	+49.0%	0.99×	+6.4%	0.93×	+24.6%	0.75×	-47.4%	1.42×	+10.7%	1.29×	-8.0%	1.40×	-15.4%	1.65×	-8.1%	1.80×	+9.7%	1.64×	-21.8%	2.10×	+15.2%	1.82×	+7.4%	1.69×	+45.1%	1.17×
Return on equity (ROE)	13.2%	+2.3 p.p.	10.9%	+9.2 p.p.	1.8%	-7.7 p.p.	9.5%	+4.1 p.p.	5.3%	-17.3 p.p.	22.7%	+3.1 p.p.	19.6%	+8.0 p.p.	11.5%	+2.8 p.p.	8.8%	+2.0 p.p.	6.8%	+0.7 p.p.	6.1%	-1.7 p.p.	7.8%	-1.2 p.p.	9.0%	+0.6 p.p.	8.5%	+2.7 p.p.	5.8%	-4.0 p.p.	9.8%	+0.8 p.p.	9.0%	+1.3 p.p.	7.7%	-5.7 p.p.	13.4%	-1.9 p.p.	15.3%	-4.2 p.p.	19.5%
Return on assets (ROA)	5.2%	+0.3 p.p.	4.9%	+4.1 p.p.	0.8%	-3.3 p.p.	4.0%	+1.8 p.p.	2.2%	-7.8 p.p.	10.0%	+1.7 p.p.	8.3%	+3.2 p.p.	5.2%	+1.3 p.p.	3.9%	+0.8 p.p.	3.1%	+0.2 p.p.	3.0%	-0.9 p.p.	3.8%	-0.9 p.p.	4.7%	+0.1 p.p.	4.6%	+1.3 p.p.	3.3%	-2.8 p.p.	6.1%	+0.6 p.p.	5.5%	+0.7 p.p.	4.9%	-3.3 p.p.	8.1%	-0.7 p.p.	8.9%	-1.5 p.p.	10.4%
Book value / share	$25.12	-3.0%	$25.89	+310.6%	$6.31	-76.5%	$26.82	+18.9%	$22.56	-3.9%	$23.46	+12.8%	$20.81	-14.3%	$24.28	+5.0%	$23.13	-17.3%	$27.95	+5.9%	$26.40	+25.8%	$20.99	-34.4%	$32.00	-4.1%	$33.36	-4.6%	$34.97	-7.6%	$37.83	-0.5%	$38.02	+12.4%	$33.83	—	—	—	—	—	—

Newest column (“Last 12M”) = trailing 12 months, the last 4 reported quarters — shown with the quarter range it spans; earlier columns are full fiscal years.

Net Debt & Leverage

Free Cash Flow

Margins

Dividend Payout Ratio

Capex ÷ Revenue

Cash Conversion (operating cash flow ÷ net income)

Ratios computed from company financial statements. Net Debt = total debt − cash & equivalents; FCF = operating cash flow − capital expenditure; absolute values in USD.

Valuation & Dividends

P/E Ratio History

Dividend History

This year (YTD) $0.19/share · yield 1.73%

Dividends and yield from Yahoo Finance (per ADR share, in US dollars). The current-year figures are calendar year-to-date (dividends actually paid this year), not the trailing 12 months.

Listings

Copel trades on 5 exchanges. Prices on this page are the NYSE ADR (ELPC).

Exchange	Ticker	Currency
NYSEpriced here	ELPC	USD
B3 (São Paulo)	CPLE3	BRL
Latibex (Madrid)	XCOPO	EUR
Frankfurt	ELP0	EUR
Mexico (BMV)	ELP	MXN

Frequently Asked Questions

Why hold Copel ELPC ADR instead of local B3 CPLE3 shares?

Buying directly on Brazil’s B3 exchange means opening a local brokerage account, converting currency and dealing with Brazilian tax paperwork. ADRs remove that friction: they settle in dollars, follow US market hours, and report in formats foreign investors already understand.

The trade-off is that an ADR’s price reflects two moving parts: (1) the underlying share price, quoted in reais on the B3, and (2) the USD/BRL exchange rate. Because of that second part, a rising company can still deliver a flat, or even negative, dollar return if the real weakens against the dollar. The same applies to ETFs: funds such as EWZ, EWZS and FLBR bundle dozens of these companies into a single ticker for instant diversification, but their dollar value still moves with the real.

Where is Copel listed?

Copel trades on 5 exchanges. The line quoted on this page is NYSE in the United States (ELPC, US dollars). It also trades on B3 (São Paulo) in Brazil (CPLE3, Brazilian reais), Latibex (Madrid) in Spain (XCOPO, euros), Frankfurt in Germany (ELP0, euros) and Mexico (BMV) in Mexico (ELP, Mexican pesos).

On how many exchanges does Copel trade?

5. NYSE — ELPC (USD) · B3 (São Paulo) — CPLE3 (BRL) · Latibex (Madrid) — XCOPO (EUR) · Frankfurt — ELP0 (EUR) · Mexico (BMV) — ELP (MXN). Prices shown on this page are the NYSE line, ELPC.

What is Copel's primary listing?

Copel's primary listing is on the B3 in Brazil, where the shares trade as CPLE3 in reais — the company's home market. The NYSE line quoted on this page is an ADR over those same shares: it gives you the asset in US dollars, on US market hours, without opening a Brazilian brokerage account or trading in reais.

What is the difference between ELPC and CPLE3?

They are the same company and, economically, the same asset. CPLE3 is the original Brazilian share, listed on the B3 and quoted in reais. ELPC is an American Depositary Receipt over that share, listed on the NYSE and quoted in US dollars — a wrapper whose purpose is to give foreign investors access to the Brazilian asset without opening an account in Brazil. The ELPC price therefore tracks two things: CPLE3 in reais, and the USD/BRL exchange rate.

How can I buy Copel stock in Europe?

Copel trades in euros on 2 European venues: Latibex (Madrid) in Spain (XCOPO) and Frankfurt in Germany (ELP0). A European broker with access to any of them can buy it in EUR, with no currency conversion on your side. The price shown on this page is the NYSE line (ELPC), quoted in US dollars.

How can I buy Copel stock in the United States?

Copel is listed on the NYSE under ELPC, priced in US dollars. Any US brokerage offering NYSE-listed securities can trade it, with no foreign-account paperwork and no currency conversion.

As of Fri, Aug 21, 17:00 BRT · Market closed

Financial data last updated: August 21, 2026

← All stocks & ETFs